MCG scan study for cardiac amyloidosis
Part of Hormones & metabolism clinical trials.
This study uses a new type of heart scan (MCG) to help understand cardiac amyloidosis. It may help doctors learn more about the condition without needing invasive tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be able to follow the study rules and give written permission
- You must not be pregnant or breastfeeding
- You must not have active atrial fibrillation on your most recent EKG
- You must not have metal implants in your chest (like a pacemaker or defibrillator)
- You must be able to lie still on your back for the scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special MRI scan to measure how stiff the heart muscle is in people with cardiac amyloidosis. The goal is to better understand the condition and potentially guide future treatments.
This study tests a new magnetic heart scan (MCG) to see if it can better detect blocked arteries causing chest pain or heart attacks. It may help doctors decide the best treatment for you.
This study uses signals from a pacemaker or defibrillator to help detect a condition called cardiac amyloidosis, where abnormal proteins build up in the heart. It may help diagnose this condition earlier without extra tests.
This study tests different heart scans to find heart amyloidosis, a condition where abnormal proteins build up in the heart, in people who have certain warning signs. The goal is to see which test works best to help diagnose it faster.
This study aims to find, describe, and track people with cardiac amyloidosis over time. It uses MRI scans and other tests to better understand the condition, which may help guide future treatment.
This study looks at how a type of heart condition called transthyretin cardiac amyloidosis changes over time, using a special imaging test called a bone scan. The goal is to see if the scan can help track the disease and potentially improve care.
Hear when a new Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.